In people with obesity or type 2 diabetes, injecting niacin decreases specific molecular signals in fat tissue that normally help prevent fat breakdown, even though niacin overall reduces fat breakdown.

40

Pro

0

Against

Evidence from Studies

Supporting (1)

40

Community contributions welcome

40

Adipose Tissue Resistance to the Antilipolytic Effect of Insulin and Niacin in Humans With Obesity.

Randomized Controlled Trial

Human

2026 Apr 1

Niacin makes fat cells stop releasing fat, even though it somehow turns down the signals that normally tell fat cells to stay quiet — like turning off a light switch but the room still stays dark.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Adipose Tissue Resistance to the Antilipolytic Effect of Insulin and Niacin in Humans With Obesity.

Score: 40

DOI: 10.2337/db25-0979

Similar Assertions

In people with obesity or type 2 diabetes, niacin still reduces fat breakdown in adipose tissue even when the usual insulin signaling pathways are less active, indicating it may use alternative biological mechanisms to achieve this effect.

40

0

85%

In people with obesity or type 2 diabetes, insulin and niacin reduce the release of free fatty acids through different early molecular mechanisms, but both ultimately affect the same later regulatory proteins to achieve similar results.

40

0

79%

In people with obesity or type 2 diabetes, the less effectively insulin reduces fat release from fat cells, the less effectively niacin does too, suggesting both substances are affected by the same underlying problem in how fat breakdown is controlled.

40

0

76%